NCT05728632 Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines Status UNKNOWN Phase PHASE3
NCT05703126 Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML Status RECRUITING Phase NA
NCT05699915 Extensive CArdioVAscular Characterization and Follow-up of Patients Receiving Immune Checkpoint Inhibitors Status TERMINATED Phase NA
NCT05508087 Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts. Status COMPLETED Phase NA
NCT05465031 Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) Status RECRUITING Phase PHASE4
NCT05406635 Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer Status RECRUITING Phase NA
NCT05377320 PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study Status NOT_YET_RECRUITING Phase N/A
NCT05349058 Assessment of Myocardial Injury in Patients Treated With Immune Checkpoint Inhibitors Status UNKNOWN Phase N/A
NCT05298072 Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients Status UNKNOWN Phase N/A
NCT05271162 Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines Status RECRUITING Phase PHASE3
NCT05159479 Defining Robust Predictors of Chemotherapy Related Cardiotoxicity Status UNKNOWN Phase N/A
NCT05150080 Early Identification and Evaluation of Cyclophosphamide Cardiotoxicity Status UNKNOWN Phase N/A
NCT05096338 Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05078190 Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05040867 Exercise Prescription Guided by Heart Rate Variability in Breast Cancer Patients Status UNKNOWN Phase NA
NCT05036252 Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity Status ACTIVE_NOT_RECRUITING Phase N/A